Your session is about to expire
← Back to Search
OMM Treatment for Parkinson's Disease
N/A
Recruiting
Led By Jayme Mancini, D.O.
Research Sponsored by New York Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Medically diagnosed with Parkinson's disease
Be over 40 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 11 week period
Awards & highlights
Study Summary
This trial will investigate whether OMM can decrease constipation symptoms in people with PD, as well as optionally changing the bacterial flora of the mouth and gut.
Who is the study for?
This trial is for individuals over 40 with Parkinson's disease who also suffer from constipation as defined by the Rome III criteria. It aims to help those looking for non-drug treatments.Check my eligibility
What is being tested?
The study tests Osteopathic Manipulative Medicine (OMM), a gentle manual treatment, to see if it reduces constipation in Parkinson's patients and possibly affects mouth and gut bacteria.See study design
What are the potential side effects?
OMM is known to be safe with minimal risk of side effects. It involves hands-on techniques that may include stretching, gentle pressure, and resistance.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Parkinson's disease.
Select...
I am over 40 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 11 week period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~11 week period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Constipation Scoring System (Cleveland Criteria)
Secondary outcome measures
Bristol Stool Scale
PAC-QOL©
PAC-SYM©
Other outcome measures
Mouth analysis
Stool analysis
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: OMM treatmentExperimental Treatment1 Intervention
Subject will receive osteopathic manipulative treatment protocol for constipation in Parkinson's disease once a week for 4 weeks, in addition to continuing with their routine care
Group II: ControlActive Control1 Intervention
Subjects will continue with their routine care. No OMM will be performed during this study period
Find a Location
Who is running the clinical trial?
New York Institute of TechnologyLead Sponsor
51 Previous Clinical Trials
2,051 Total Patients Enrolled
Jayme Mancini, D.O.Principal InvestigatorNew York Institute of Technology- Academic Health Care Center
To Shan Li, D.O.Principal InvestigatorNew York Institute of Technology- Academic Health Care Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are eligible for this research study?
"Affirmative. Information available on clinicaltrials.gov indicates that the trial which was first posted in January 1st, 2015 is still recruiting patients for participation. The most recent update to this study occurred November 3rd 2021 and it requires a total of 20 participants from one medical centre."
Answered by AI
Are there any available opportunities for enrolment in this clinical trial?
"Data hosted on clinicaltrials.gov indicates that enrollment is in progress for this experiment, which was originally uploaded to the website on January 1st 2015 and last edited November 3rd 2021."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger